Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain.
Saved in:
| Title: | Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain. |
|---|---|
| Authors: | Ogata A; Department of Pharmacy, Faculty of Pharmacy, Gifu University of Medical Science (GUMS), Kani, Japan; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan. Electronic address: aogata@u-gifu-ms.ac.jp., Yamada T; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Hattori S; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Ikenuma H; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Abe J; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Tada M; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan., Ichise M; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Suzuki M; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Ito K; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Kato T; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan., Amaike K; Graduate School of Science, Nagoya University, Nagoya, Japan., Hirota T; Institute of Transformative Bio-Molecules (WPI-ITbM) Nagoya University, Nagoya, Japan., Kakita A; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan., Itami K; Graduate School of Science, Nagoya University, Nagoya, Japan; Institute of Transformative Bio-Molecules (WPI-ITbM) Nagoya University, Nagoya, Japan., Kimura Y; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), Obu, Japan. Electronic address: yazkim@ncgg.go.jp. |
| Source: | Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Jun 15; Vol. 90, pp. 129327. Date of Electronic Publication: 2023 May 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
